Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice. 2003

Salvatore Cuzzocrea, and Antonietta Rossi, and Barbara Pisano, and Rosanna Di Paola, and Tiziana Genovese, and Nimesh S A Patel, and Elisabetta Cuzzocrea, and Angela Ianaro, and Lidia Sautebin, and Francesco Fulia, and Prabal K Chatterjee, and Achille P Caputi, and Christoph Thiemermann
Institute of Pharmacology, School of Medicine, Torre Biologicala, Policlinico Universitario, University of Messina, Via C. Valeria Gazzi, 98100, Messina, Italy. salvator@www.unime.it

OBJECTIVE Nuclear factor (NF) kappaB is a transcription factor which plays a pivotal role in the induction of genes involved in physiological processes as well as in the response to injury and inflammation. Dithiocarbamates are anti-oxidants which are potent inhibitors of NF-kappaB. We postulated that pyrrolidine dithiocarbamate (PDTC) would attenuate multiple-organ failure (MOF). METHODS Rats in a university research laboratory. METHODS We investigated the effects of PDTC (10 mg/kg) on the MOF caused by zymosan (500 mg/kg, administered i.p. as a suspension in saline) in mice. MOF in mice was assessed 18 h after administration of zymosan and/or PDTC and monitored for 7 days (for loss of body weight and mortality). RESULTS Treatment of mice with PDTC (10 mg/kg i.p., 1 and 6 h after zymosan) attenuated the peritoneal exudation and the migration of polymorphonuclear cells caused by zymosan. PDTC also attenuated the lung, liver and pancreatic injury and renal dysfunction caused by zymosan as well as the increase in myeloperoxidase activity and malondialdehyde levels caused by zymosan in the lung, liver and intestine. Immunohistochemical analysis for inducible nitric oxide synthase, nitrotyrosine and poly(ADP-ribose) revealed positive staining in lung, liver and intestine tissues obtained from zymosan-treated mice. The degree of staining for nitrotyrosine and poly(ADP-ribose) were markedly reduced in tissue sections obtained from zymosan-treated mice which received PDTC. Furthermore, treatment of mice with PDTC significantly reduced the expression of nitric oxide synthase in lung, liver and intestine. CONCLUSIONS This study provides the first evidence that PDTC attenuates the degree of zymosan-induced MOF in mice.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D009102 Multiple Organ Failure A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative. MODS,Multiple Organ Dysfunction Syndrome,Organ Dysfunction Syndrome, Multiple,Organ Failure, Multiple,Failure, Multiple Organ,Multiple Organ Failures
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011065 Poly(ADP-ribose) Polymerases Enzymes that catalyze the transfer of multiple ADP-RIBOSE groups from nicotinamide-adenine dinucleotide (NAD) onto protein targets, thus building up a linear or branched homopolymer of repeating ADP-ribose units i.e., POLY ADENOSINE DIPHOSPHATE RIBOSE. ADP-Ribosyltransferase (Polymerizing),Poly ADP Ribose Polymerase,Poly(ADP-Ribose) Synthase,Poly(ADP-ribose) Polymerase,PARP Polymerase,Poly ADP Ribose Transferase,Poly ADP-Ribose Synthase,Poly(ADP-Ribose) Transferase,Poly(ADPR) Polymerase,Poly(ADPribose) Polymerase,Poly ADP Ribose Synthase,Polymerase, PARP,Synthase, Poly ADP-Ribose
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random

Related Publications

Salvatore Cuzzocrea, and Antonietta Rossi, and Barbara Pisano, and Rosanna Di Paola, and Tiziana Genovese, and Nimesh S A Patel, and Elisabetta Cuzzocrea, and Angela Ianaro, and Lidia Sautebin, and Francesco Fulia, and Prabal K Chatterjee, and Achille P Caputi, and Christoph Thiemermann
May 2011, European journal of pharmacology,
Salvatore Cuzzocrea, and Antonietta Rossi, and Barbara Pisano, and Rosanna Di Paola, and Tiziana Genovese, and Nimesh S A Patel, and Elisabetta Cuzzocrea, and Angela Ianaro, and Lidia Sautebin, and Francesco Fulia, and Prabal K Chatterjee, and Achille P Caputi, and Christoph Thiemermann
May 2013, Pathology, research and practice,
Salvatore Cuzzocrea, and Antonietta Rossi, and Barbara Pisano, and Rosanna Di Paola, and Tiziana Genovese, and Nimesh S A Patel, and Elisabetta Cuzzocrea, and Angela Ianaro, and Lidia Sautebin, and Francesco Fulia, and Prabal K Chatterjee, and Achille P Caputi, and Christoph Thiemermann
February 2009, Shock (Augusta, Ga.),
Salvatore Cuzzocrea, and Antonietta Rossi, and Barbara Pisano, and Rosanna Di Paola, and Tiziana Genovese, and Nimesh S A Patel, and Elisabetta Cuzzocrea, and Angela Ianaro, and Lidia Sautebin, and Francesco Fulia, and Prabal K Chatterjee, and Achille P Caputi, and Christoph Thiemermann
November 1997, American journal of respiratory cell and molecular biology,
Salvatore Cuzzocrea, and Antonietta Rossi, and Barbara Pisano, and Rosanna Di Paola, and Tiziana Genovese, and Nimesh S A Patel, and Elisabetta Cuzzocrea, and Angela Ianaro, and Lidia Sautebin, and Francesco Fulia, and Prabal K Chatterjee, and Achille P Caputi, and Christoph Thiemermann
January 2002, British journal of pharmacology,
Salvatore Cuzzocrea, and Antonietta Rossi, and Barbara Pisano, and Rosanna Di Paola, and Tiziana Genovese, and Nimesh S A Patel, and Elisabetta Cuzzocrea, and Angela Ianaro, and Lidia Sautebin, and Francesco Fulia, and Prabal K Chatterjee, and Achille P Caputi, and Christoph Thiemermann
January 2009, Journal of biomedicine & biotechnology,
Salvatore Cuzzocrea, and Antonietta Rossi, and Barbara Pisano, and Rosanna Di Paola, and Tiziana Genovese, and Nimesh S A Patel, and Elisabetta Cuzzocrea, and Angela Ianaro, and Lidia Sautebin, and Francesco Fulia, and Prabal K Chatterjee, and Achille P Caputi, and Christoph Thiemermann
February 2010, Pharmacological research,
Salvatore Cuzzocrea, and Antonietta Rossi, and Barbara Pisano, and Rosanna Di Paola, and Tiziana Genovese, and Nimesh S A Patel, and Elisabetta Cuzzocrea, and Angela Ianaro, and Lidia Sautebin, and Francesco Fulia, and Prabal K Chatterjee, and Achille P Caputi, and Christoph Thiemermann
September 2016, Oncotarget,
Salvatore Cuzzocrea, and Antonietta Rossi, and Barbara Pisano, and Rosanna Di Paola, and Tiziana Genovese, and Nimesh S A Patel, and Elisabetta Cuzzocrea, and Angela Ianaro, and Lidia Sautebin, and Francesco Fulia, and Prabal K Chatterjee, and Achille P Caputi, and Christoph Thiemermann
February 2010, Journal of inflammation (London, England),
Salvatore Cuzzocrea, and Antonietta Rossi, and Barbara Pisano, and Rosanna Di Paola, and Tiziana Genovese, and Nimesh S A Patel, and Elisabetta Cuzzocrea, and Angela Ianaro, and Lidia Sautebin, and Francesco Fulia, and Prabal K Chatterjee, and Achille P Caputi, and Christoph Thiemermann
June 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Copied contents to your clipboard!